171 related articles for article (PubMed ID: 9816747)
1. [AIDS triple therapy. The gap between viral load and side effects].
Gürtler L
Fortschr Med; 1998 Sep; 116(27):4-5. PubMed ID: 9816747
[No Abstract] [Full Text] [Related]
2. Nonnucleoside reverse transcriptase inhibitors.
Murphy RL
AIDS Clin Care; 1997 Oct; 9(10):75-7, 79. PubMed ID: 11364757
[TBL] [Abstract][Full Text] [Related]
3. The end of AIDS?
Leland J
Newsweek; 1996 Dec; 128(23):64-8, 71, 73. PubMed ID: 10162943
[No Abstract] [Full Text] [Related]
4. Undetectable HIV levels after triple therapy with indinavir.
AIDS Patient Care STDS; 1997 Jun; 11(3):193-4. PubMed ID: 11361795
[No Abstract] [Full Text] [Related]
5. Lipodystrophy--nukes vs. protease inhibitors.
TreatmentUpdate; 2001 Jul; 13(3):5-6. PubMed ID: 11569989
[No Abstract] [Full Text] [Related]
6. Drug interactions, toxicities, dosages: trials and tribulations and cocktails.
Crit Path AIDS Proj; 1998; (No 33):9-17. PubMed ID: 11366377
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of drug cocktail combinations for their immunological value in preventing/remitting opportunistic infections.
Konlee M
Posit Health News; 1998; (No 16):2-4. PubMed ID: 11365016
[TBL] [Abstract][Full Text] [Related]
8. To AIDS and back with Norvir, D4T, 3TC and nutritional therapies. An interview with Michael Golk.
Golk M
Posit Health News; 1998; (No 16):5-7. PubMed ID: 11365018
[TBL] [Abstract][Full Text] [Related]
9. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy.
Reiser M; Salzberger B; Stiepel A; Hoetelmans R; Diehl V; Fätkenheuer G
Eur J Med Res; 1999 Feb; 4(2):54-8. PubMed ID: 10066640
[TBL] [Abstract][Full Text] [Related]
10. [Non-nucleoside reverse transcriptase inhibitor as a fully viable alternative. Strong therapy start without protease inhibitor].
MMW Fortschr Med; 2000 Mar; 142 Suppl 1():30-3. PubMed ID: 10863307
[No Abstract] [Full Text] [Related]
11. Rescue me.
Simmons P
Res Initiat Treat Action; 1998 Aug; 4(5):10. PubMed ID: 11365705
[TBL] [Abstract][Full Text] [Related]
12. Initiation of antiretroviral therapy: implications of recent findings.
Saag MS
Top HIV Med; 2004; 12(3):83-8. PubMed ID: 15310939
[TBL] [Abstract][Full Text] [Related]
13. Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1.
Clevenbergh P; Kirstetter M; Liotier JY; Dupon M; Philibert P; Jacomet C; Cua E; Montagne N; Schmit JC; Dellamonica P
Antivir Ther; 2002 Dec; 7(4):305-8. PubMed ID: 12553486
[TBL] [Abstract][Full Text] [Related]
14. Ritonavir and saquinavir combination: 12-week data at ICAAC.
James JS
AIDS Treat News; 1996 Oct; (No 256):3. PubMed ID: 11363880
[TBL] [Abstract][Full Text] [Related]
15. Improvement in CD4+ cell counts despite persistently detectable HIV load.
Levitz SM
N Engl J Med; 1998 Apr; 338(15):1074-5. PubMed ID: 9537882
[No Abstract] [Full Text] [Related]
16. [Treatment of HIV infections and AIDS with protease inhibitor and two nucleoside analogs].
Jensen-Fangel S; Larsen L; Thomsen HF; Nielsen LP; Black FT; Obel N
Ugeskr Laeger; 1999 Mar; 161(12):1751-4. PubMed ID: 10210974
[TBL] [Abstract][Full Text] [Related]
17. Another take on when to start and how to succeed.
Friedland GH
AIDS Clin Care; 2001 Sep; 13(9):82. PubMed ID: 11547600
[No Abstract] [Full Text] [Related]
18. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
Michelet C; Bellissant E; Ruffault A; Arvieux C; Delfraissy JF; Raffi F; Bazin C; Renard I; Sébille V; Chauvin JP; Dohin E; Cartier F
Clin Pharmacol Ther; 1999 Jun; 65(6):661-71. PubMed ID: 10391672
[TBL] [Abstract][Full Text] [Related]
19. AIDS researchers emphasize new drug combinations.
Fox JL
Nat Biotechnol; 1997 Mar; 15(3):215. PubMed ID: 9062914
[No Abstract] [Full Text] [Related]
20. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.
Negredo E; Paredes R; Bonjoch A; Tuldrà A; Fumaz CR; Gel S; Garcés B; Johnston S; Arnó A; Balagué M; Jou A; Tural C; Sirera G; Romeu J; Cruz L; Francia E; Domingo P; Arrizabalaga J; Ruiz I; Arribas JR; Ruiz L; Clotet B
Antivir Ther; 1999; 4 Suppl 3():23-8. PubMed ID: 16021868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]